Showing 1 - 10 of 44
As people live longer, chronic illness care will consume an ever-larger part of a nation's financial resources. With the Disease management is built on a model of integrated care, with each member of the healthcare team working together toward a common set of objectives. The ultimate goal is to...
Persistent link: https://www.econbiz.de/10005243014
Persistent link: https://www.econbiz.de/10005243015
Persistent link: https://www.econbiz.de/10005243070
The changing demographic profile of the world's population towards old age and evidence of people living for longer with less time spent in ill health highlight the importance of addressing quality-of-life (QOL) assessment issues for older people. The assessment of health-related QOL (HR-QOL)...
Persistent link: https://www.econbiz.de/10005243157
Introduction: Excellent treatment outcomes with long-term durability and few adverse effects are expectations of treatments for chronic conditions. The long-term cost effectiveness of newer treatments for benign prostatic hyperplasia (BPH), including high-energy transurethral microwave...
Persistent link: https://www.econbiz.de/10005243187
Background:Background: Studies have determined the societal impact of methicillin-resistant Staphylococcus aureus (MRSA) by modelling its impact on labour supply and productivity. In addition, most of the studies on the topic conclude that the problem of resistance should be counteracted on the...
Persistent link: https://www.econbiz.de/10010552622
Background: The Investigating Choice Experiments for the Preferences of Older People (ICEPOP) programme developed a capability-based measure of general quality of life (QOL): the ICEPOP CAPability (ICECAP-O) instrument. ICECAP-O was originally intended for use in the economic evaluation of...
Persistent link: https://www.econbiz.de/10010614257
This article uses data from a cohort of elderly and retired persons over the 1996-2001 period in the US to (i) determine the extent to which changes in socioeconomic or demographic characteristics, particularly age, income and education, impact the total amount that is spent on prescription...
Persistent link: https://www.econbiz.de/10004990318
Background and objective: The SENIORS trial demonstrated that nebivolol is effective in the treatment of heart failure in elderly patients (e.g. =70 years). This analysis evaluates the cost effectiveness of nebivolol compared with standard treatment. Methods: An individual patient-simulation...
Persistent link: https://www.econbiz.de/10004997789
The National Service Framework for Older People (NSF), published recently by the Department of Health in England, represents a major initiative to improve services for this group of patients. It describes an ambitious 10-year plan to address ageism, person-centered care, hospital care,...
Persistent link: https://www.econbiz.de/10005448799